BN II System
Confidence in plasma protein results
The BN™ II System and its nephelometric technology provide uncompromising performance in plasma protein analysis. The menu covers assays to support a variety of clinical indications, such as cardiac risk assessment, kidney diseases, nutritional assessment, and innovative markers such as monoclonal kappa and lambda free light chains, Cystatin C and Carbohydrate-Deficient Transferrin (CDT).
The products/features (mentioned herein) are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens organization for further details.